• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Marksans Pharma Limited — Updates, 05-11-2025: Press Release

    05-11-2025 | 09:18 am

    Marksans Pharma's UK subsidiary, Relonchem, secured UK regulatory approval for its Exemestane 25mg tablets. This greenlights market entry for the product, paving the way for potential sales growth in the UK.

    No comments yet. Be the first to comment!

    All announcements from Marksans Pharma Limited